Warren Buffett is sitting on $325 billion in cash – his largest hoard ever.

Not because he wants to – but because he can’t find value in the usual places.

Now, as US government spending spirals out of control, Buffett knows he’s losing billions of dollars to inflation. 

That’s why I predict Buffett’s next investment will catch millions of people off guard. 

It’s not another bank… railroad company… or more shares of Apple. 

It’s a gold company. How do I know?

Because the math doesn’t lie:

You can buy the average gold developer for $30 and get back $13 a year —

That’s a 43% ROI annually.

Over 10 years, that’s $130 on a $30 investment.

Tell me where else Buffett can get that.

But there’s one specific miner Buffett likes best:

• It’s the best-managed major gold miner in the industry…
• Has massive cash flow…
• Is trading at a deep discount to fair value…
• Positioned at the heart of Trump’s new mining push…

Don’t wait for Buffett to reveal his position in his 13F filing on February 17th…

Right now, you have the chance to front-run the greatest investor of all time. Go here and I’ll give you the name and ticker – along with details on my top four small miners.

To your wealth,

Garrett Goggin, CFA, CMT
Chief Analyst & Founder, Golden Portfolio

P.S. A lot of investors write in to tell me how much they’ve made in Bitcoin. My reply? Good for you. First off, gold investing is cyclical. You really only want to own gold at one specific time in the cycle. That time is now. Second, the world’s governments are not buying Bitcoin. They’re betting on gold. All of them. Bitcoin (does anyone really know for sure the US government didn’t create it?) will be a good bet… until it isn’t. It may end up doing great. Or it may be eclipsed by any number of tech developments. 

Meanwhile, gold will continue to do what it’s done for almost 6,000 years of recorded human history: Protect wealth through chaos. Go here if you want the name and ticker of Buffett’s likely gold play… and details on my top four miners

---

Just For You

5 Stocks and ETFs to Help Shield Your Portfolio During Volatility

Authored by Ryan Hasson. Article Published: 2/9/2026. 

What You Need to Know

• Rising volatility and sharp sector rotations are pressuring growth stocks, pushing investors to reassess downside exposure and portfolio resilience.
• Defensive areas like healthcare, consumer staples, and dividend-focused ETFs are attracting capital as tech-led weakness and risk-off behavior intensify.
• Resilient stocks and ETFs offering steady demand and dividend yields may help investors weather further market turbulence without abandoning equity exposure.

The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated volatility, sharp rotations, and growing uncertainty have begun to erode market confidence, and that’s often when portfolio positioning matters most.

Periods like this naturally force investors to ask an important question: How vulnerable am I if the market pulls back further? Whether the current environment becomes a routine correction or something more prolonged, history shows certain sectors, ETFs, and stocks tend to hold up better than the broader market when sentiment weakens.

Executive Order 14330: Trump’s Biggest Yet (Ad)

While President Trump’s official salary is $400,000 per year… his tax returns reveal he’s been collecting up to $250,000 PER MONTH from one hidden source. Until recently, most Americans couldn’t touch the type of investment that makes up this investment. But thanks to Executive Order 14330, that just changed. If you love investing in disruptive new companies…Discover how to invest in the fund Trump uses to collect this income >>

Much of the turbulence so far has been driven by the tech sector. After leading the market for years, tech stocks have struggled under the weight of stretched valuations and heavy AI-related capital spending. Software has been hit particularly hard, with the iShares Expanded Tech-Software Sector ETF (BATS: IGV) down nearly 22% year-to-date. That weakness has sparked a broader rotation out of high-growth names and into more defensive areas of the market.

Adding fuel to the fire are lingering tariff concerns, a weakening U.S. dollar, and a sharp correction in crypto markets. Bitcoin alone has fallen nearly 40% from last year’s record highs, amplifying risk-off behavior across equities. When multiple risk assets unwind at once, investors tend to favor durability over upside.

For those looking to play defense or balance growth exposure with protection, the market offers several options that have historically performed well in volatile or declining environments. Some benefit from steady demand regardless of economic conditions, others offer income through dividends, and a few provide both.

Here are five stocks and ETFs investors may want to consider if market volatility persists or deepens.

Healthcare Sector ETF: Defensive Demand Meets Bullish Technicals

Healthcare has long been viewed as one of the market’s most reliable defensive sectors, and the current setup reinforces that reputation. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) provides broad exposure to healthcare giants spanning pharmaceuticals, biotechnology, medical devices, and healthcare services.

The sector’s defensive appeal is straightforward: medical care is not discretionary. Regardless of economic conditions, people still need prescriptions, treatments, insurance, and medical equipment. That steady demand helps insulate revenue and cash flow during downturns, making healthcare stocks more resilient than cyclical sectors tied to consumer spending or capital investment.

XLV also offers an income component, with a 1.6% dividend yield, along with strong liquidity and deep institutional participation. Average daily trading volume consistently exceeds 14 million shares, ensuring efficient entry and exit points for investors.

What makes XLV particularly interesting right now is its positioning. The ETF has been consolidating for several months in a bullish continuation pattern. The $160 level has served as a key resistance zone since 2024, and the fund now sits just below it. A confirmed breakout would likely attract additional momentum-driven capital.

Fund flows also support the thesis. XLV has recorded positive inflows year-to-date, signaling growing institutional interest as investors rotate toward defensive exposure. From a composition standpoint, the ETF is well balanced, with roughly 54% exposure to biotechnology, 28% to healthcare equipment and supplies, and 13% to healthcare providers and services.

If volatility remains elevated, healthcare’s combination of steady fundamentals and improving technicals positions XLV as a compelling defensive allocation.

Johnson & Johnson: A Healthcare Blue Chip With Momentum

Within the healthcare space, few companies embody stability quite like Johnson & Johnson (NYSE: JNJ). The diversified healthcare giant has delivered strong performance this year, with shares up almost 16% year-to-date and nearly 40% over the past six months.

JNJ’s defensive characteristics are rooted in its business model. The company operates across pharmaceuticals, medical devices, and consumer health products—categories that see consistent demand regardless of the economic cycle. That diversification smooths earnings and reduces reliance on any single product line.

In many ways, Johnson & Johnson sits at the intersection of healthcare and consumer staples. Its products are essential, recurring purchases rather than discretionary expenses, making revenue streams more predictable during periods of economic stress.

The company is also a Dividend King, boasting a 64-year streak of dividend increases. JNJ currently offers a 2.2% dividend yield and a strong payout ratio of 47%, giving investors both income and balance sheet strength.

Institutional behavior further reinforces the bullish case. Over the past 12 months, Johnson & Johnson has attracted $38.5 billion in institutional inflows versus $25.4 billion in outflows, resulting in meaningful net buying. Wall Street sentiment remains constructive, with a consensus Moderate Buy rating based on more than two dozen analyst opinions.

Consumer Staples ETF: A Classic Defensive Anchor

Consumer staples have historically served as a safe harbor during periods of market stress, and the current environment is no exception. The Consumer Staples Select Sector SPDR Fund (NYSEARCA: XLP) offers exposure to companies that produce everyday necessities—products consumers continue to buy regardless of economic conditions, such as toothpaste, household cleaners, packaged foods, beverages, and personal care items.

Demand for these goods tends to remain stable even during recessions, allowing companies like Walmart (NASDAQ: WMT), Procter & Gamble (NYSE: PG), and Coca-Cola (NYSE: KO) to maintain consistent revenue and earnings.

That reliability is what gives consumer staples their defensive reputation. During prior downturns, including the 2008 financial crisis, the sector generally outperformed more cyclical areas like technology and financials.

XLP enhances that defensive appeal with diversification and income. The ETF manages close to $17 billion in assets, carries a dividend yield of about 2.45%, and trades nearly 23 million shares per day on average.

From a technical standpoint, XLP has been one of the strongest performers this year. The ETF has surged more than 13% year-to-date, dramatically outperforming the S&P 500, and it recently broke above a multi-year resistance level—an indication of a potential regime shift for the sector.

Coca-Cola: Defensive Consistency With Dividend Power

For investors seeking individual stock exposure in consumer staples, Coca-Cola (NYSE: KO) stands out as a high-quality option. The beverage giant has enjoyed a strong start to the year, building on momentum that already made last year one of its better openings in recent history.

Unlike some rallies driven by a single company, this year’s strength appears closely tied to a broader resurgence in consumer staples. That sector-wide tailwind adds credibility to Coca-Cola’s move higher.

KO’s defensive nature stems from its product mix. Beverages like Coke, Sprite, and Dasani are affordable, habitual purchases that consumers rarely cut back on, even during economic downturns. That contrasts sharply with discretionary categories that tend to suffer when sentiment weakens.

Coca-Cola is also a Dividend King, with 64 consecutive years of dividend increases. The stock currently offers a dividend yield of roughly 2.6% and a payout ratio of nearly 68%, making it attractive to income-focused investors.

Analyst sentiment remains favorable: Coca-Cola holds a consensus Buy rating based on 16 analyst opinions, with modest upside still projected. Combined with sector momentum and defensive fundamentals, KO remains well positioned if market volatility continues.

Vanguard High Dividend Yield ETF: Diversification and Income in One Package

For investors seeking broad diversification and income, dividend-focused ETFs can play a valuable defensive role. These funds reduce single-stock risk while providing regular cash flow, which can help offset market declines.

One standout option is the Vanguard High Dividend Yield ETF (NYSEARCA: VYM). The fund tracks a diversified basket of high-quality, dividend-paying companies across multiple sectors. With over $73 billion in assets under management and a low expense ratio of just 0.06%, VYM is both efficient and scalable.

The ETF currently yields 2.25% and has significantly outperformed the broader market this year, rising more than 8% year-to-date compared with the S&P 500’s modest gains. That outperformance reflects its limited exposure to high-volatility technology stocks and greater weighting toward defensive and income-generating sectors.

VYM’s portfolio is spread across financials (22%), technology (16%), healthcare (13%), consumer staples (11%), and energy (8%), with additional exposure to utilities, materials, and consumer discretionary. The ETF’s diversification helps smooth returns across different market environments and is especially appealing for investors looking to balance growth exposure with income and downside protection.

Diversification Could Result in Protection and Performance

Market volatility is uncomfortable, but it’s not entirely unpredictable. Every cycle brings periods of uncertainty, and portfolios that account for that reality tend to fare better over time.

Healthcare, consumer staples, and dividend-focused strategies have consistently proven their worth during market pullbacks. Whether through broad ETFs such as XLV, XLP, and VYM, or high-quality individual stocks such as Johnson & Johnson and Coca-Cola, investors have multiple ways to play defense without exiting the market entirely.

As the year unfolds and uncertainty lingers, positioning for resilience may matter just as much as chasing returns.

This email message is a paid advertisement for Golden Portfolio, a third-party advertiser of MarketBeat. Why was I sent this email message?. 

If you have questions or concerns about your account, please email our South Dakota based support team at contact@marketbeat.com.

If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.

© 2006-2026 MarketBeat Media, LLC. 
345 North Reid Place #620, Sioux Falls, S.D. 57103-7078. USA..

Read More: Trump’s Final Shocking Act Begins February 24(From Banyan Hill Publishing)